logo
episode-header-image
Jul 2021
35m 24s

Novel Lipid-Lowering Therapies to Reduce...

JAMA NETWORK
About this episode

Several new therapeutic drug classes are now available to manage lipid levels. John Wilkins, MD, MS, and Donald Lloyd-Jones, MD, ScM, of the Department of Preventive Medicine and Division of Cardiology at Northwestern University Feinberg School of Medicine, discuss the use of ezetimibe, PCSK-9 inhibitors, bempedoic acid, and icosapent ethyl to manage lipid levels in patients taking statins who require additional LDL lowering.

Related Content:

Up next
Oct 1
Treatment of Severe Refractory Asthma
Severe refractory asthma, which affects approximately 1% to 5% of patients with asthma, is associated with increased morbidity and mortality. Author Juan Carlos Cardet, MD, MPH, of the University of South Florida joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the man ... Show More
14m 39s
Sep 30
From the JAMA Network: Acetaminophen Use in Pregnancy and Risk of Autism
Epidemiologist Brian Lee, PhD, discusses his study on acetaminophen use during pregnancy and children’s risk of autism and other neurodevelopmental disorders in this interview with JAMA Deputy Editor Linda Brubaker, MD. Related Content: Acetaminophen Use in Pregnancy—Study Author ... Show More
16m 56s
Sep 24
Five Things to Do When Communicating Medical Numbers
Health care professionals often use numbers to guide decisions, monitor patient health, and communicate information. Author Angela Fagerlin, PhD, of the University of Utah joins JAMA Senior Editor Anne Cappola, MD, ScM, to discuss how providing numerical information may be helpfu ... Show More
15m 50s
Recommended Episodes
Jul 2019
LDL-Senkung 4.0
Kombinationspartner zur Statintherapie in Sicht? Studientelegramm 72-2019-2/3 Titel der Studie: Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol Autoren: Ray et al. Journal: New England Journal of Medicine (NEJM) Studientelegramm 72-2019-3/3 Titel der Studie: Mende ... Show More
8m 59s
May 2022
207. Lipids: REDUCE-IT Versus STRENGTH Trials – EPA in Clinical Practice with Dr. Peter Toth
CardioNerds Tommy Das (Program Director of the CardioNerds Academy and cardiology fellow at Cleveland Clinic), Rick Ferraro (cardiology fellow at the Johns Hopkins Hospital), and Dr. Aliza Hussain (cardiology fellow at Baylor College Medicine) take a deep dive on the REDUCE-IT tr ... Show More
53m 59s
Sep 2021
143. Lipids: (Non)-Fasting LDL & Furious Lipid Lowering with Dr. Alison Bailey
CardioNerds Dr. Rick Ferraro, Director of the #CardsJC Journal Club and cardiology fellow at Johns Hopkins, and Dr. Tommy Das, Program Director of the CardioNerds Academy and cardiology fellow at Cleveland Clinic, learn all about the clinical application of the ASCVD primary and ... Show More
35m 49s
Jan 2024
ACCEL Lite: Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
While we know that statin treatment reduces the risk of stroke, heart attack and heart deaths in people at moderate-to-high risk, or with high cholesterol, in REPRIEVE statins decreased the risk in those at low-to-moderate risk, and with 'normal' cholesterol levels who would not ... Show More
11m 46s
Jun 2024
#525: Cholesterol-Lowering Medication – Dr. Paddy Barrett
Cholesterol-lowering medications, particularly statins, play a pivotal role in reducing low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (apoB) concentrations, which are causal markers in atherosclerosis development. The efficacy of these medications is well-docum ... Show More
48m 29s
Sep 2023
When Hyperkalemia Impairs Optimal Treatment of HF and CKD: What New Guidelines Recommend
Suboptimal dosing of renin-angiotensin-aldosterone system inhibitors (RAASi) therapy is associated with doubling of mortality. Experts discuss new options for intensification of RAASi in heart failure with reduced ejection fraction (HFrEF).    Credit available for this activity e ... Show More
31m 24s
May 2023
#255 ‒ Latest therapeutics in CVD, APOE’s role in Alzheimer’s disease and CVD, familial hypercholesterolemia, and more | John Kastelein, M.D., Ph.D.
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter John Kastelein is a renowned expert in lipoprotein metabolism and atherosclerotic cardiovascular disease (ASCVD) research. In this discussion, John ... Show More
2h 4m
Nov 2023
Nurturing young minds and beyond: The Omega-3 connection
Acting Department Chair and Canada Research Chair in Brain Lipid Metabolism. Dr. Bazinet and his team are currently taking a kinetic and biochemical approach to studying the mechanisms by which dietary polyunsaturated fatty acids regulate the metabolism of arachidonic and docosah ... Show More
39m 17s
Jun 2021
Glipizide Pharmacology
Glipizide, or Glucotrol, is a sulfonylurea used for the treatment of Type 2 Diabetes. Pharmacologically, glipizide acts by stimulating beta-cells in the pancreas to release insulin. Specifically, glipizide will block the opening of ATP-sensitive potassium channels on the plasma m ... Show More
12m 46s
Listen to millions of songs and podcasts on Anghami